foscarnet has been researched along with fosfomycin in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (35.71) | 29.6817 |
2010's | 8 (57.14) | 24.3611 |
2020's | 1 (7.14) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Csanaky, I; Gregus, Z | 1 |
Armstrong, RN; Fillgrove, KL; Newcomer, ME; Rife, CL; Rigsby, RE | 1 |
Arakawa, Y; Jin, W; Kawamura, K; Kimura, K; Nakamura, G; Sato, N; Shibayama, K; Wachino, J; Yagi, T; Yamada, K | 1 |
Cooper, VS; Doi, Y; Guo, Q; McElheny, CL; Sluis-Cremer, N; Stoesser, N; Tomich, AD; Wang, M | 1 |
Arlet, G; Benzerara, Y; Decré, D; Gallah, S; Genel, N; Hommeril, B; Rottman, M | 1 |
Doi, Y; Ito, R; McElheny, CL; Mettus, RT; Sluis-Cremer, N; Tomich, AD | 1 |
Garneau-Tsodikova, S; Gilbert, NC; Green, KD; Thompson, MK; Travis, S; Tsodikov, OV | 1 |
1 review(s) available for foscarnet and fosfomycin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
13 other study(ies) available for foscarnet and fosfomycin
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
Effect of phosphate transporter and methylation inhibitor drugs on the disposition of arsenate and arsenite in rats.
Topics: Arsenates; Arsenites; Biotransformation; Carrier Proteins; Catechols; Foscarnet; Fosfomycin; Methylation; Nitriles; Nitrous Oxide; Phosphates; Tissue Distribution | 2001 |
Phosphonoformate: a minimal transition state analogue inhibitor of the fosfomycin resistance protein, FosA.
Topics: Bacterial Proteins; Binding Sites; Catalysis; Crystallization; Crystallography, X-Ray; Drug Resistance, Bacterial; Foscarnet; Fosfomycin; Glutathione Transferase; Kinetics; Manganese; Organophosphonates; Pseudomonas aeruginosa | 2004 |
Practical agar-based disk potentiation test for detection of fosfomycin-nonsusceptible Escherichia coli clinical isolates producing glutathione S-transferases.
Topics: Agar; Anti-Bacterial Agents; Culture Media; DNA, Bacterial; Drug Tolerance; Escherichia coli; Escherichia coli Infections; Foscarnet; Fosfomycin; Glutathione Transferase; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Pseudomonas aeruginosa; Sequence Analysis, DNA | 2014 |
Glutathione-S-transferase FosA6 of Klebsiella pneumoniae origin conferring fosfomycin resistance in ESBL-producing Escherichia coli.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; DNA, Bacterial; Drug Resistance, Bacterial; Enzyme Inhibitors; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Foscarnet; Fosfomycin; Genome, Bacterial; Glutathione Transferase; Humans; Kinetics; Microbial Sensitivity Tests; Plasmids; Sequence Analysis, DNA; Urine | 2016 |
Emergence of Plasmid-Mediated Fosfomycin-Resistance Genes among Escherichia coli Isolates, France.
Topics: Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Foscarnet; Fosfomycin; France; Gene Expression; Humans; Isoenzymes; Microbial Sensitivity Tests; Plasmids; Prevalence | 2017 |
Inhibition of Fosfomycin Resistance Protein FosA by Phosphonoformate (Foscarnet) in Multidrug-Resistant Gram-Negative Pathogens.
Topics: Anti-Bacterial Agents; Antiviral Agents; Drug Repositioning; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Enterobacter cloacae; Escherichia coli; Escherichia coli Proteins; Foscarnet; Fosfomycin; Kinetics; Klebsiella pneumoniae; Microbial Sensitivity Tests; Protein Isoforms; Pseudomonas aeruginosa; Recombinant Proteins | 2017 |
Inhibition of Fosfomycin Resistance Protein FosB from Gram-Positive Pathogens by Phosphonoformate.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Drug Resistance, Bacterial; Foscarnet; Fosfomycin; Microbial Sensitivity Tests; Staphylococcus aureus; Transferases | 2023 |